$VTEX

Gomide de Faria Mariano sold $20K of VTEX (indirect holdings)

Gomide de Faria Mariano (Chief Executive Officer) sold 4,808 indirectly-held shares of VTEX (VTEX) at $4.22 on 2026-07-20 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Gomide de Faria Mariano
Published Jul 21, 2026, 5:40 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 21, 2026, 5:45 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$VTEX
Neutral
medium confidence
Mentioned
$VTEX
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VTEXNeutralLow
01

Why it matters

This provides incremental transparency on insider activity but does not introduce new fundamentals or company-specific catalysts.

02

Market read

Traders may monitor insider activity for sentiment, but the 10b5-1 framing reduces the signal strength.

03

What to watch

Indirect holdings and the post-transaction share count are provided, but the article does not indicate whether other insiders sold/bought around the same window or whether the plan size is typical.

Relevance 2/10Novelty 3/10Timing: Filed on 2026-07-21, covering a sale executed on 2026-07-20.

Background

The article is an SEC Form 4 insider transaction disclosure for VTEX, reported as an open-market sale by the CEO via an indirect holding.

Company-level read

Ticker impact

$VTEXNeutralMedium confidence
Context

SEC Form 4 shows CEO Gomide de Faria Mariano sold 4,808 shares of VTEX at $4.2200 on a 10b5-1 plan.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven rather than fundamental.

Evidence & confidence

The filing is a routine insider transaction with stated 10b5-1 pre-arrangement, and the article provides no accompanying company-specific catalyst (earnings, contract, investigation, or guidance change).

Market effects

No clear sector read-through; this is an issuer-specific insider sale without additional business context.

None indicated.

None indicated.

Counterpoint

The sale is on a pre-arranged 10b5-1 plan, so it may reflect diversification or liquidity needs rather than bearish expectations.

Key entities

  • VTEX

    Company whose CEO insider sale is disclosed on SEC Form 4.

  • Gomide de Faria Mariano

    VTEX CEO who sold 4,808 shares at $4.2200 under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$VTEXMed

VTEX (VTEX) Just Turned A Profit Corner, But Growth Is Slowing

VTEX (NYSE:VTEX) reported Q2 2026 results showing improved profitability with non-GAAP income from operations up 62.4% YoY to $13.8M, and free cash flow up 79.1% to $12.7M. However, revenue growth slowed to 1.3% YoY on an FX-neutral basis, with management expecting flat growth for Q3. The company repurchased 6.2M shares for $23.2M during the quarter.

$VTEXMedAI 8/10

VTEX (VTEX) Q2 2026 Earnings Call Transcript

VTEX reported Q2 2026 results in an earnings call. GMV was $5.7B, up 7% FX-neutral. Subscription revenue was $63.8M, up 1.3% FX-neutral. Non-GAAP operating income rose 62% to $13.8M, with a 21.4% margin. Free cash flow was $12.7M, up 79%. Q3 guidance calls for flat FX-neutral subscription growth.

$VTEXMedAI 8/10

VTEX Q2 Earnings Call Highlights

VTEX (NYSE:VTEX) reported Q2 margin and cash flow improvement and guided for Q3 and full-year low-single-digit FX-neutral subscription revenue growth and low-20% non-GAAP operating and free cash flow margins. Q2 non-GAAP subscription gross margin rose to 81.8%. Free cash flow rose 79% to $12.7M. VTEX repurchased 6.2M shares at $3.76.

$VTEXMed

VTEX (VTEX): Financial results for Q2 2026

VTEX (VTEX) furnished an SEC Form 6-K — earnings release. VTEX Reports Second Quarter 2026 Financial Results Subscription revenue grew 11.4% (+1.3% FXN), with GMV up 17.8% (+7.0% FXN) Non-GAAP income from operations increased 62.4% to US$13.8 million, reaching a 21.4% margin Free cash flow increased 79.1% to US$12.7 million, reaching a